Literature DB >> 10695930

Apolipoprotein E polymorphism: automated determination of apolipoprotein E2, E3, and E4 isoforms.

C Wiebe1, G Holzem, K Wielckens, K R Klingler.   

Abstract

Apolipoprotein E (apo E) plays an essential role in lipoprotein metabolism, where it is involved in the clearance of chylomicrons and very low density lipoproteins. Apart from some rare variants, apo E exists in three common isoforms (E2, E3, and E4). The different isoforms have not only been associated with different plasma lipid levels but have also been correlated with certain pathological conditions, such as lipid disorders (dysbetalipoproteinemia, hypercholesterolemia), cardiovascular diseases, and Alzheimer's disease. Here we describe a rapid, automated test for the determination of the most frequent polymorphisms (E2, E3, and E4). This polymerase chain reaction-based test allows the reliable discrimination of all six genotypes. The assay has been developed especially for the nonspecialized routine clinical laboratory by employing an analyzer and chemistry often present in this type of laboratory. Because of its low costs and easy handling, the assay can be performed on a daily basis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695930     DOI: 10.1007/s11745-000-0500-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves.

Authors:  C Aslanidis; G Schmitz
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype.

Authors:  S Kataoka; M Paidi; B V Howard
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

4.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

Review 5.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

6.  [Genotyping of apolipoprotein E (alleles epsilon 2, epsilon 3 and epsilon 4) from capillary blood].

Authors:  J P Lagarde; P Benlian; L Zekraoui; A Raisonnier
Journal:  Ann Biol Clin (Paris)       Date:  1995       Impact factor: 0.459

7.  Population frequency of apolipoprotein E5 (Glu3-->Lys) and E7 (Glu244-->Lys, Glu245-->Lys) variants in western Japan.

Authors:  A Matsunaga; J Sasaki; K Moriyama; F Arakawa; Y Takada; K Nishi; K Hidaka; K Arakawa
Journal:  Clin Genet       Date:  1995-08       Impact factor: 4.438

8.  Rapid identification of the common apo E isoform genotype using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP).

Authors:  R Aozaki; R Kawaguchi; U Ogasa; K Hikiji; N Kubo; I Sakurabayashi
Journal:  Mol Cell Probes       Date:  1994-02       Impact factor: 2.365

9.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

Authors:  W J Schneider; P T Kovanen; M S Brown; J L Goldstein; G Utermann; W Weber; R J Havel; L Kotite; J P Kane; T L Innerarity; R W Mahley
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

Review 10.  Apolipoprotein E: an important gene and protein to follow in laboratory medicine.

Authors:  G Siest; T Pillot; A Régis-Bailly; B Leininger-Muller; J Steinmetz; M M Galteau; S Visvikis
Journal:  Clin Chem       Date:  1995-08       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.